Brief: Orchestra Biomed Holdings Says Expectation Is Initiation Of Virtue Isr-Us Pivotal Study Evaluating Efficacy Of Virtue Sab To Be Postponed Till 2024
10/10/2023 22:35
Oct 10 (Reuters) - Orchestra Biomed Holdings Inc
OBIO.O :
* ORCHESTRA BIOMED HOLDINGS- EXPECTATION IS INITIATION OF
VIRTUE
ISR-US PIVOTAL STUDY EVALUATING EFFICACY OF VIRTUE SAB TO BE
POSTPONED TILL 2024
Further company coverage: OBIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Orchestra Biomed Holdings
See all newsBrief: Orchestra Biomed Announces Pricing Of Public Offering
Orchestra BioMed slides after starting equity offering
Brief: Orchestra Biomed Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Orchestra Biomed Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Orchestra BioMed Q2 revenue drops, net loss widens